Coroner seeks review of unapproved peptides after actor's death
An Australian coroner has called for regulatory action following the death of a 75-year-old actor who used prescribed but unapproved peptides.
At a glance
- Richard Norton, 75, experienced cardiac arrest in March 2025 after injecting unapproved peptides
- The peptides CJC1295 and ipamorelin were prescribed but not approved for use
- A coroner has requested the TGA review the substances
- The case may result in tougher restrictions on unapproved peptides
Richard Norton, a 75-year-old Australian actor, stuntman and fight choreographer, died after cardiac arrest in March 2025 following injection of prescribed but unapproved peptides CJC1295 and ipamorelin.
A coroner has called for the Therapeutic Goods Administration to review the substances, potentially leading to stricter regulations on unapproved peptides.
Why it matters
The death raises questions about regulatory oversight of peptides and could lead to stricter controls on substances currently available through prescription but lacking official approval.
Original reporting
This brief was written with AI assistance from the reports listed above and checked against our editorial policy. Spotted an error? Request a correction.
